Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Oncotarget|May 21, 2019
Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterationsFrank Griscelli, Christophe Desterke, Olivier Feraud, et al.
Stem Cell Research|September 20, 2017
Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutationFrank Griscelli, Olivier Feraud, Tony Ernault, et al.
Stem Cells Translational Medicine|November 25, 2020
Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failureChristophe Desterke, Frank Griscelli, Jusuf Imeri, et al.
Frontiers in Medicine|November 1, 2021
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and OncologyAli G Turhan, Jinwook W Hwang, Diana Chaker, et al.
Leukemia & Lymphoma|October 9, 2010
Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemiaJean-Claude Chomel, Nathalie Sorel, Marie-Laure Bonnet, et al.
Cancer Research|April 5, 2005
p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expressionJean-Francois Geay, Dorothée Buet, Yanyan Zhang, et al.
Leukemia & Lymphoma|May 9, 2008
Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemiaClaire Villalva, Nathalie Sorel, Marie-Laure Bonnet, et al.
Frontiers in Oncology|April 3, 2023
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillanceJusuf Imeri, Christophe Desterke, Paul Marcoux, et al.
Stem Cell Research|March 30, 2018
Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutationFrank Griscelli, Hélène Ezanno, Mathis Soubeyrand, et al.
Biochimica Et Biophysica Acta. General Subjects|January 25, 2020
A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC)Jin Wook Hwang, Julien Loisel-Duwattez, Christophe Desterke, et al.
Pageof 9